Benedikt Schoser, MD
Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany
2
1
2
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+12 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Araya Puwanant, MD, MS
Wake Forest University Health Sciences
Shared therapeutic areas:
Priya Kishnani
Duke University
Shared therapeutic areas:
Paolo Banfi, MD
IRCCS Fondazione Don Carlo Gnocchi
Shared therapeutic areas:
Regina Trollmann, MD
University Hospital Erlangen
Shared therapeutic areas:
Dwight d Koeberl, MD, PhD
Duke University
Shared therapeutic areas:
Stephan Wenninger, PD Dr. med.
Neurologist
Shared therapeutic areas:
Worked with same sponsors:
Barry J. Byrne, MD, PhD
University of Florida
Shared therapeutic areas:
Isabel Illa, MD pHD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Worked with same sponsors:
whu-Liang Hwu, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Barry J Byrne, MD, PhD
University of Florida
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Clinical Outcome Measures in Myotonic Dystrophy Type 2
Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)
All 2 trials loaded